Intuitive narrows 2026 procedure growth outlook to 14%-15% amid I&A pricing actions targeting 3%-5% per-procedure reduction (NASDAQ:ISRG)
· seekingalpha.com
Intuitive Surgical (ISRG) Q3 2026 earnings call recap: procedure growth, da Vinci/Ion adoption, guidance updates, pricing & margin risks.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...